CNTN is the largest pan-Canadian bilingual nephrology trials network consisting of more than 130 Canadian investigators across 14 centers, bringing together nephrologists, investigators and patients to deliver high quality national and international clinical trials. In the last three years alone, despite the negative impact of COVID-19 on clinical research, the network provided in-depth peer review to eight clinical studies of which four received endorsement and three received national peer-reviewed funding, emphasizing the strength of our network in supporting clinical trials of broad national importance. The CNTN is under the governance of Can-SOLVE CKD, a CIHR pan-Canadian SPOR supported patient oriented research network. Thus, the CNTN emphasizes direct engagement of patients and Indigenous peoples, both as members and co-leaders of our network committees. In doing so, we ensure that the clinical trials we support place the patient at the forefront.